Atom Bioscience
Pharmaceuticals - Suzhou, Jiangsu, China
Atom Bioscience Employees
Atom Bioscience Senior Management
Atom Bioscience Details
Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.) is a clinical stage biotechnology company founded in 2012. Atom is developing best-in-class orally delivered small molecule drugs for treatment of inflammatoryand metabolic diseases, such as chronic gout and non-alcoholic steatohepatitis (NASH) for which there are no effective treatments.Atom's lead therapy, ABP-671, for chronic gout, is more potent and significantly less toxic than existing drugs, and is poised to enter global Phase 3 trials in 2022. Another compound, ABP-6016, has demonstrated safety and efficacy in preclinical trials for NASH, which is projected to become the most common cause of liver disease.To learn more about Atom Bioscience visit our website.
Atom Bioscience Technologies
Email Providers
Outlook
Load Balancers
Nginx
CMS
WordPress.org
Fonts
Google Font API
Other
Mobile Friendly